Artificial Intelligence

Blockchain firm BTCS is overhauling executive pay to prioritize profitability, a move signaling a strategic shift for the maturing crypto industry.

After wooing celebrities at the Oscars, wellness tech brand ibreo is betting its global success and patent-rich technology can conquer the U.S. market.

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

Transamerica's new AI assistant, Pearl, promises to cut retirement account consolidation from weeks to days. Is this the future of personal finance?

A new one-time gene therapy shows it can clear toxic brain plaques in preclinical studies, offering a potential path to halt or even reverse Alzheimer's.

Jet.AI and its partner advance their massive Canadian data center projects, securing natural gas and renewable energy to fuel the future of artificial intelligence.

In a bid to reshape the AI hardware market, Celestica and AMD are joining forces on an open-standards platform to compete with established players.

Pactum's new Requisition Alignment Agent automates compliance and negotiation in enterprise systems, promising huge savings and a new role for human buyers.

As FullPAC sponsors the 2026 Pollie Awards, its focus on AI and a planned public listing reveal a strategy to reshape how elections are won.

San Diego biotech elevates key execs as it advances its inflammation pipeline, backed by Sanofi and Lilly, into a competitive and high-stakes market.

Global esports prize money soared to $270M in 2025, but a new report reveals how Saudi Arabia, China, and the US host nearly half, raising big questions.

A $20M investment fuels Chorus Intelligence's AI-driven police software, sparking debate over efficiency gains versus ethical and privacy concerns.

A new compound could make CAR-T cell therapy more durable and less costly, showing promise against both cancer and HIV in groundbreaking new research.

A landmark partnership between Realta Fusion and Kyoto Fusioneering merges American physics with Japanese engineering to accelerate the path to commercial fusion.

ProNexis is deploying a new AI platform that mixes automation with human agents, aiming to perfect the customer journey and unlock revenue from old leads.

Nasus Pharma's NS002 nasal spray reached critical therapeutic levels in half the time of EpiPen, heralding a potential new era for anaphylaxis treatment.

The electronics manufacturer lands a major contract for C-UAS ground stations, fueling its €1.5B growth plan and bolstering European defense capabilities.

Bloomway AI launches its CinePro public beta, promising to democratize filmmaking with an AI that "thinks like a director." But can it deliver?

Historic auction house Bonhams partners with analytics firm ARTDAI, betting on AI and big data to gain a competitive edge in the evolving art world.

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.